PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

A Selective P2Y Purinergic Receptor Agonist 2-MesADP Enhances Locomotor Recovery after Acute Spinal Cord Injury.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32474563 ↗2020Reported benefit

A Selective P2Y Purinergic Receptor Agonist 2-MesADP Enhances Locomotor Recovery after Acute Spinal Cord Injury.

MouseSpinal cord injuryCompressionGiven after T9 crush injury, with assessment up to 6 weeks

Model: T9 crush spinal cord injury (acute)

2-MesADP improved limb motor function by 6 weeks after injury with neuronal regeneration and axon remyelination at 2 and 6 weeks, and altered expression of apoptosis, regeneration and myelination genes (Nefh, NeuroD6, Dcx, Mag, Mog, Cnp), with Wnt signalling identified as the most affected pathway.

Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.